Evidence map›Paper›PMID 35806330›Full record

ArticleInternational journal of molecular sciences2022

Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates.

Alexandre Pelletier, Arnaud Carrier, Yongmei Zhao, Mickaël Canouil, Mehdi Derhourhi, Emmanuelle Durand, Lionel Berberian-Ferrato, John Greally, Francine Hughes, Philippe Froguel and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Alexandre PelletierInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.ORCID 0000-0003-2979-2470
Arnaud CarrierInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.ORCID 0000-0002-9200-7685
Yongmei ZhaoDepartment of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Mickaël CanouilInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.ORCID 0000-0002-3396-4549
Mehdi DerhourhiInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.
Emmanuelle DurandInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.
Lionel Berberian-FerratoInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.
John GreallyDepartment of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Price Building, Room 322, Bronx, NY 10461, USA.
Francine HughesObstetrics & Gynecology and Women's Health, Division of Maternal-Fetal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.ORCID 0000-0001-5801-4526
Philippe FroguelInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.
Amélie BonnefondInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.ORCID 0000-0001-9976-3005
Fabien DelahayeInserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, 59000 Lille, France.ORCID 0000-0002-9921-8653
Centre National de la Recherche Scientifique · FRAlbert Einstein College of Medicine · US

Funding

SUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SOPHIE MOLHOLM, Steven Upshaw Walkley · 2021 to 2026
$7.0M
UNDERSTANDING CELLULAR AND TRANSCRIPTIONAL REGULATORY CHANGES IN HUMAN AGINGR01AG057422 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GREALLY, JOHN, LAPPALAINEN, TUULI · 2018 to 2022
$4.5M
Genome-wide DNA Methylation Profiles Associated with Abnormal Intrauterine GrowthR01HD063791 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GREALLY, JOHN, HUGHES EINSTEIN, FRANCINE · 2009 to 2013
$2.0M
European Research Council ERC Reg-Seq - 715575Medical Research Council MR/R010676/1NIA NIH HHS R01 AG057422NICHD NIH HHS P50 HD105352NICHD NIH HHS R01 HD063791NIH HHS R01 HD063791
6 · The paper itself

Abstract

Excessive fetal growth is associated with DNA methylation alterations in human hematopoietic stem and progenitor cells (HSPC), but their functional impact remains elusive. We implemented an integrative analysis combining single-cell epigenomics, single-cell transcriptomics, and in vitro analyses to functionally link DNA methylation changes to putative alterations of HSPC functions. We showed in hematopoietic stem cells (HSC) from large for gestational age neonates that both DNA hypermethylation and chromatin rearrangements target a specific network of transcription factors known to sustain stem cell quiescence. In parallel, we found a decreased expression of key genes regulating HSC differentiation including

Indexed as

Diabetes, GestationalTranscriptomeEpigenesis, GeneticEpigenomicsFemaleFetal MacrosomiaGestational AgeHematopoiesisHematopoietic Stem CellsHumansInfant, NewbornPregnancyepigenomicsfetal programminghematopoiesissingle-cellstem-cells

Identifiers

PMID35806330
PMCPMC9267056
OpenAlexW4283737792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.